Hasil Pencarian  ::  Simpan CSV :: Kembali

"Di Indonesia proporsi Bayi Berat Lahir Rendah (BBLR) <2500 gram pada bayi umur 0-59 bulan masih cukup tinggi, yaitu 6,2% di tahun 2013-2018. Padahal kondisi BBLR memiliki risiko lebih besar untuk mengalami morbiditas dan mortalitas dari pada bayi dengan berat badan normal. Salah satu masalah terbesar yang sering dialami BBLR adalah peningkatan risiko untuk terserang infeksi maupun sepsis, sehingga obat yang paling banyak digunakan di unit perawatan intensif neonatus adalah dari golongan antibiotik. Oleh sebab itu, diperlukannya peran Apoteker dalam melakukan praktik profesi berupa Pemantauan Terapi Obat (PTO) dalam proses pengobatan agar dapat membantu dalam mengoptimalkan efek terapi dan meminimalkan efek yang tidak dikehendaki sehingga prognosisnya dapat menjadi lebih baik. Pelaksanaan PTO dilakukan pada tanggal 15-24 September 2020 bertempat di ruang perinatologi 2B di gedung bougenville RSUP Fatmawati berdasarkan laporan kasus yang bersifat kualitatif dengan melakukan pengamatan langsung atau observasi. Data yang diperoleh kemudian diidentifikasi terkait Drug Related Problems (DRPs) menurut Cipolle dan dianalisis rasionalitasnya pada domain antibiotik dengan metode Gyssens. Dari analisa yang dilakukan ditemukan beberapa masalah DRP menurut Cipolle yaitu terkait lama pemberian obat meropenem yang terlalu panjang; pemberian dosis yang terlalu rendah pada obat fluconazole dan ketorolac; pemilihan obat bactesyn yang tidak rasional; adanya interaksi obat fluconazole dengan omeprazole yang bersifat moderat, serta interaksi obat gentamicin dengan bactesyn yang bersifat minor jika digunakan secara bersamaan. Sementara hasil evaluasi menggunakan metode Gyssens pada penggunaan antibiotik menunjukkan obat meropenem termasuk kategori IIIa (penggunaan antibiotik terlalu lama); gentamicin termasuk kategori 0 (penggunaan antibiotika tepat/bijak); bactesyn termasuk katagori IVa (ada antibiotik lain yang lebih efektif) dan katagori IIa (penggunaan antibiotik tidak tepat dosis) apabila tetap dipertahankan penggunaannya.

---

In Indonesia, the proportion of Low Birth Weight Babies (LBW) <2500 grams in infants aged 0-59 months is still quite high at 6.2% in 2013-2018. In fact, LBW conditions have a greater risk of experiencing morbidity and mortality than babies with normal weight. One of the biggest problems that are often experienced by LBW is the increased risk for infection and sepsis, so the most widely drugs used in neonatal intensive care units are from the antibiotic class. Therefore, a pharmacist's role is needed in carrying out professional practice with Drug Therapy Monitoring (DTM) in order to help optimize the effect of therapy and minimize unwanted effects, so the prognosis can be better. The implementation of DTM was carried out on September 15-24, 2020 at the perinatology room 2B in the bougenville building of RSUP Fatmawati based on qualitative case reports by direct observation. Then the data was identified using the Drug Related Problems (DRPs) classification according to Cipolle and analyzed their rationality in the antibiotic domain using the Gyssens method. From the analysis conducted, it was found that several DRP problems were related to the the long duration of administration of meropenem; too low a dose of fluconazole and ketorolac; irrational choice of bactesyn; There is a moderate drug interaction between fluconazole and omeprazole, as well as a minor drug interaction between gentamicin and bactesyn when used concurrently. Meanwhile, the results of the evaluation using the Gyssens method on antibiotic use showed that meropenem was included in category IIIa (the use of antibiotic is too long); gentamicin was included in category 0 (the use of antibiotics is appropriate/wise); bactesyn was included category IVa (there are other antibiotics that are more effective) and category IIa (the use of antibiotics is not in the right dose) if its use is maintained."

"Pemantauan Terapi Obat pada Neonatus Kurang Bulan, Bayi Berat Lahir Rendah, dan Sepsis di Ruang Neonatus Intensive Care Unit (NICU) RSUP Fatmawati Bulan September 2020.

---

Neonates, especially preterm infants have weak physical defenses and immature immune function, making them susceptible to bacterial invasion. One of the efforts to achieve the Sustainable Development Goals (SDGs), which is to reduce the incidence of neonatal mortality to 12 per 1,000 live births, it is necessary to collaborate between health workers in treating patients. Pharmacists in hospitals need to carry out their roles, one of which is by monitoring the therapy given. Data were collected directly by looking at the cardex and patient's medical records with the following criteria: less-month neonatal patients, receiving polypharmacy, patients with antibiotic therapy, and length of stay in the hospital ≥5 days. The data obtained were analyzed using the SOAP method and identified problems related to drugs. From the Monitoring of Drug Therapy (PTO), it was found that drug-related problems that occurred were dose mismatches and frequency mismatches, and analysis of the evaluation of antibiotic administration (EPA) with the Gyssens method found that the use of antibiotics was found in category IIIa, namely giving meropenem too long and category IIa, which was not the right dosage."

"Pemantauan Terapi Obat (PTO) merupakan proses yang mencakup kegiatan seperti pengkajian terkait obat yang digunakan pasien, pemberian rekomendasi penyelesaian masalah terkait obat serta pemantauan efektivitas dan efek samping obat. Data penggunaan obat merupakan komponen penting dalam proses PTO. Analisis yang dapat dilakukan berdasarkan data penggunaan obat adalah penilaian kualitas penggunaan antibiotik serta analisis MTO pengobatan yang diterima pasien. Masalah Terkait Obat (MTO) yang terjadi pada pengobatan pasien dan memberikan rekomendasi tindak lanjut menggunakan metode SOAP. PTO dilakukan pada pasien berinisial NAN yang didiagnosis sindrom gangguan pernapasan akut, perdarahan intraserebral dan PDVK. Masalah Terkait Obat (MTO) yang terjadi pada pengobatan pasien N di ruangan PICU RSUP Fatmawati dengan diagnosis sindrom gangguan pernapasan akut, perdarahan intraserebral dan PDVK adalah adanya ketidaksesuaian dosis yaitu amikasin 1x60 mg. Kemudian ditemukan Reaksi Obat yang Tidak Diinginkan (ROTD) terjadi pada pasien yaitu hipoalbumin yang merupakan ROTD dari parasetamol dan hiperglikemi akibat pemberian deksametason. Interaksi obat yang terjadi yaitu antara amikasin dan mannitol, asam valproate dan meropenem, parasetamol dan fenitoin, fenitoin dan asam valproate, amikasin dan furosemide, seftriakson dan furosemide, serta omeprazole dan fenitoin. Penilaian kualitas penggunaan antibiotik menggunakan metode gyssens menunjukkan bahwa penggunaan antibiotik seftriakson sudah tepat atau bijak karena masuk ke dalam kategori 0. Kemudian Penggunaan meropenem masuk kategori IVA dan IIIA yang menginterpretasikan bahwa ada antibiotik lain yang lebih efektif daripada meropenem karena berdasarkan hasil kultur yaitu seftazidim dan sefepim masih sensitif terhadap pasien serta penggunaan antibiotik terlalu lama (lebih dari 14 hari). Penggunaan amikasin masuk kategori IIA dan IIB yang menunjukkan bahwa dosis dan interval yang tidak tepat.

---

Drug Therapy Monitoring (DTM) is a process that includes activities such as assessments related to drugs used by patients, providing recommendations for solving drug-related problems, and monitoring the effectiveness and side effects of drugs. Drug use data is an important component of the DTM process. Analysis that can be carried out based on drug use data is an assessment of the quality of antibiotic use as well as an DRP analysis of the treatment the patient receives. Drug-Related Problems (DRP) that occur in patient treatment and provide follow-up recommendations using the SOAP method. DTM was performed on a patient with the initials NAN who was diagnosed with acute respiratory distress syndrome, intracerebral hemorrhage, and PDVK. Drug-Related Problems (DRP) that occurred in the treatment of patient N in the PICU room at Fatmawati Hospital with a diagnosis of acute respiratory distress syndrome, intracerebral hemorrhage, and PDVK was a dose mismatch, namely amikacin 1x60 mg. Then it was found that adverse drug reactions (ADR) occurred in patients, namely hypoalbumin which was ADR from paracetamol, and hyperglycemia due to dexamethasone administration. Drug interactions that occur are between amikacin and mannitol, valproic acid and meropenem, paracetamol and phenytoin, phenytoin and valproic acid, amikacin and furosemide, ceftriaxone and furosemide, and omeprazole and phenytoin. Assessment of the quality of antibiotic use using the Gyssens method showed that the use of ceftriaxone was appropriate or wise because it was included in category 0. Then the use of meropenem was included in categories IVA and IIIA which interpreted that other antibiotics were more effective than meropenem because they were based on culture results, namely ceftazidime and cefepime. still sensitive to patients and the use of antibiotics for too long (more than 14 days). The use of amikacin is in categories IIA and IIB which shows that the dose and interval are incorrect."

"Bayi berat lahir rendah (BBLR) memiliki ukuran vena yang sangat kecil sehingga memiliki resiko dilakukan pemasangan akses intravena perifer dengan beberapa kali penusukan. Penelitian ini bertujuan untuk mengetahui dampak dari pemasangan akses intravena perifer berulang pada BBLR. Desain penelitian menggunakan cross sectional melibatkan 211 responden di salah satu rumah sakit rujukan di Jakarta dengan teknik consecutive sampling. Hasil uji korelasi Spearman menunjukan adanya hubungan yang bermakna antara pemasangan akses intravena perifer berulang pada BBLR dengan peningkatan nyeri, peningkatan frekuensi nadi, peningkatan frekuensi nafas, penurunan saturasi oksigen, penurunan suhu tubuh, durasi menangis bayi, keterlambatan terapi, durasi pemasangan dan tingginya biaya perawatan dengan nilai (p<0,001). Pada penelitian ini, sebagian besar responden memiliki usia gestasi 32-36 minggu, berat lahir 1501-2499 gram, dan berjenis kelamin laki-laki. Penelitian ini diharapkan dapat dijadikan landasan dalam pengembangan tindakan preventif untuk mengurangi dampak pemasangan akses intravena perifer berulang pada bayi berat badan lahir rendah.

---

Low birth weight babies (LBW) have a very small size of vein so that they have the risk to do peripheral intravenous access by multiple insertion. This research aims to determine the impact of multiple insertion on intravenous access to LBW. The research design uses a cross sectional  involving 211 respondents in a referral hospital in Jakarta with consecutive sampling. The Spearman correlation test results show that there is a significant relation between multiple insertion on intravenous parifer in LBW with increased pain, increased pulse frequency, increased breath frequency, decreased oxygen saturation, decreased body temperature, duration of crying babies, delay in therapy, duration of installation and high cost of treatment with value (p<0,001). In this research, most of respondent have gestational age about 32-36 weeks, 1501-2499 grams of birth weight, and male sex. This research is expected to be used as a basis for developing preventive measures to reduce the impact of the multiple insertion on peripheral intravenous access for low birth weight babies."

"Pemantauan terapi obat (PTO) merupakan kegiatan yang dilakukan untuk memastikan terapi obat aman, efektif, dan rasional bagi pasien. Pemantauan terapi obat dilakukan dengan menganalisis pilihan obat, dosis, cara pemberian obat, respon terapi, reaksi obat yang tidak diinginkan (ROTD), serta rekomendasi perubahan maupun alternatif terapi. Pemantauan terapi obat telah termasuk sebagai salah satu pelayanan farmasi klinis pada standar pelayanan kefarmasian di rumah sakit, puskesmas, dan apotek yang diatur oleh kementerian kesehatan RI. Sepsis merupakan respons sistemik pejamu terhadap infeksi, saat patogen atau toksin dilepaskan ke dalam sirkulasi darah sehingga terjadi aktivasi proses inflamasi. Sepsis merupakan salah satu masalah kesehatan dengan tingkat kejadian kasus serta kematian yang cukup tinggi dan terus meningkat di seluruh dunia. Meskipun telah terdapat berbagai panduan terkait terapi sepsis yang dibuat oleh para ahli untuk menurunkan angka kematian akibat sepsis, minimnya pengetahuan SDM, ketersediaan pemeriksaan penunjang dan modalitas terapi menjadi alasan sulitnya pengimplementasian panduan terapi sepsis secara menyeluruh di Indonesia. Penelitian dilakukan dengan pengambilan data menggunakan metode retrospektif. Pengumpulan data dilakukan dengan mengambil data dari rekam medis pasien yang kemudian dianalisis untuk mengetahui apakah terdapat masalah terkait obat atau DRP (Drug Related Problem). Data yang diambil berupa data identitas pasien, kajian status klinik, hasil pemeriksaan penunjang, dan profil penggunaan obat. Daari data yang dikumpulkan, dilakukan beberapa analisis, yakni interpretasi hasil pemeriksaan laboratorium, analisis penggunaan antibiotik, analisis ketepatan terapi, dan analisis masalah terkait obat/DRP. Berdasarkan hasil pemantauan terapi obat, dapat disimpulkan bahwa pengobatan yang diberikan mayoritas sudah sesuai dan tidak ada masalah. Namun, terdapat beberapa masalah terapi yang kemudian dianalisis DRP nya dengan metode SOAP pada pasien. Solusi yang diberikan yaitu perlunya dilakukan pengecekan terhadap masalah terapi obat yang muncul terutama potensi interaksi obat bagi pasien yang mendapatkan obat polifarmasi, serta selalu melakukan pemantauan terhadap tanda-tanda vital pasien maupun pemeriksaan lab apabila ada kemungkinan muncul efek samping obat.

---

Drug therapy monitoring is an activity carried out to ensure the drug therapy is safe, effective and rational for patients. Drug therapy monitoring is carried out by analyzing drug choices, dosages, methods of drug administration, therapeutic response, adverse drug reactions (ADR), as well as recommendations for changes or alternative therapies. Drug therapy monitoring has been included as one of the clinical pharmacy services at pharmaceutical service standards in hospitals, health centers, and pharmacies regulated by the Indonesian Ministry of Health. Sepsis is a systemic response of the host to infection, when pathogens or toxins are released into the blood circulation resulting in the activation of the inflammatory process. Sepsis is a health problem with a high incidence of cases and deaths and continues to increase throughout the world. Although there have been various guidelines related to sepsis therapy made by experts to reduce mortality, the lack of knowledge of human resources, the availability of supporting examinations, and therapeutic modalities are the reasons for the difficulty in implementing comprehensive sepsis therapy guidelines in Indonesia. This research was carried out by collecting data using a retrospective method. Data collection was carried out by taking data from the patient's medical record which was then analyzed to find out whether there were drug-related problems or DRP. The data taken including the patient identity data, clinical status studies, results of supporting examinations, and drug use profiles. From the data collected, several analyzes were carried out, namely interpretation of laboratory examination results, analysis of antibiotic use, analysis of appropriateness of therapy, and analysis of drug-related problems/DRP. Based on the results of drug therapy monitoring, it can be concluded that the majority of the treatment given is appropriate and there are no problems. However, there were several potential therapeutic problems which were then analyzed by DRP using the SOAP method in patients. The solution given is the need to check drug therapy problems that arise, especially the potential for drug interactions for patients receiving polypharmacy drugs, and always monitor the patient's vital signs and lab tests if there is a possibility of drug side effects."

"Seorang apoteker memiliki peran penting dalam praktek pelayanan kesehatan di rumah sakit dan apotek. Apoteker harus memenuhi standar kompetensi sebagai persyaratan untuk memasuki dunia kerja dan menjalani praktek keprofesiannya. Standar kompetensi apoteker di Indonesia terdiri dari sepuluh standar kompetensi sebagai kemampuan yang diharapkan oleh apoteker saat lulus dan masuk ke tempat praktek kerja profesi. Sebagai bekal dan pengalaman calon apoteker untuk dapat memahami peran apoteker dan meningkatkan kompetensi, maka dilaksanakan Praktik Kerja Profesi Apoteker (PKPA) di RSUP Fatmawati dan Apotek Dini selama periode bulan Februari-Juni 2020. Selama PKPA, calon apoteker diharapkan dapat memperluas wawasan, pemahaman, dan pengalaman untuk melakukan pekerjaan kefarmasian di tempat praktik kerja profesi.

---

A pharmacist has an important role in health services in hospitals and pharmacies. Pharmacists must meet competency standards as a requirement to enter professional work practice and undergo professional practice. Pharmacist competency standards in Indonesia consist of ten competency standards as the skills expected by pharmacists when they graduate and enter professional work practices. As a provision and experience for prospective pharmacists to be able to understand the role of pharmacists and improve competence, an internship was carried out at RSUP Fatmawati and Apotek Dini during the period February-June 2020. During internship, prospective pharmacists are expected to broaden their horizons, understanding, and experience doing pharmaceutical work in a professional work practices."

"Pemantauan Terapi Obat (PTO) merupakan serangkaian kegiatan untuk memastikan bahwa terapi obat yang diberikan kepada pasien bersifat aman, efektif, dan rasional. Penelitian ini menganalisis Pemantauan Terapi Obat (PTO) pasien spondilitis tuberkulosis di RSUP Fatmawati. Studi dilakukan untuk mengevaluasi masalah terapi obat, memberikan rekomendasi intervensi, serta memahami peran apoteker dalam pelayanan farmasi klinis. Berdasarkan evaluasi menggunakan metode PCNE dan Gyssens, beberapa masalah terkait obat ditemukan, seperti penggunaan antibiotik yang berpotensi efek samping, durasi pemberian obat yang tidak sesuai, dan interaksi obat. Intervensi yang dilakukan melibatkan penyesuaian regimen obat untuk meminimalkan risiko Reaksi Obat Tidak Dikehendaki (ROTD) dan meningkatkan efektivitas terapi. Hasil menunjukkan bahwa kombinasi obat antituberkulosis (OAT) yang diberikan pasien, yaitu rifampisin dan etambutol, sudah sesuai dengan panduan klinis, tetapi ditemukan beberapa kejadian masalah terkait obat lain, seperti risiko hepatotoksik pada kombinasi rifampisin dan parasetamol serta interaksi ceftriaxone dengan larutan infus. Intervensi terhadap masalah tersebut berhasil diselesaikan. Analisis Gyssens mengidentifikasi bahwa pemilihan antibiotik cefixime sebaiknya menggunakan alternatif yang lebih aman untuk perawatan lanjutan. Kesimpulannya, PTO membantu meningkatkan kualitas terapi pasien dan mencegah risiko ROTD. Diharapkan, PTO terus dilaksanakan sejak awal perawatan hingga pasca-perawatan untuk mencapai terapi yang lebih optimal.

---

Drug Therapy Monitoring encompasses a series of activities to ensure that patient medication is safe, effective, and rational. This study analyzed Drug Therapy Monitoring for tuberculosis spondylitis patients at RSUP Fatmawati. The study aimed to evaluate drug-related problems (DRPs), provide intervention recommendations, and understand the pharmacist's role in clinical pharmacy services. Based on evaluations using the PCNE and Gyssens methods, several drug-related issues were identified, such as the use of antibiotics with potential adverse effects, inappropriate drug durations, and drug interactions. Interventions involved adjusting drug regimens to minimize the risk of Adverse Drug Reactions (ADRs) and enhance therapeutic efficacy. The findings showed that the antituberculosis drug combination (rifampicin and ethambutol) administered to patients aligned with clinical guidelines. However, some drug-related issues were noted, such as hepatotoxic risk from the combination of rifampicin and paracetamol and interactions between ceftriaxone and infusion solutions. These issues were successfully resolved through interventions. The Gyssens analysis identified that cefixime could be substituted with safer alternatives for long-term treatment. In conclusion, this monitoring improves the quality of patient therapy and reduces ADR risks. Continuous from admission to post-care is recommended to optimize therapy and ensure patient safety. "

"Pemantauan terapi secara berkala mengenali interaksi obat gejala efek samping lebih awal dapat mencegah reaksi obat yang tidak dikehendaki (ROTD) pada pengobatan pasien. Anemia dapat terjadi karena perdarahan baik akut maupun kronis mengakibatkan penurunan total sel darah merah. Pendarahan saluran gastrointestinal bagian bawah dengan keluarnya darah segar sewaktu buang air besar disebut hematochezia. Tuberkulosis ekstra paru perlu diwaspadai pada orang hidup dengan HIV/AIDS(ODHA) karena kejadiannya lebih sering dibandingkan TB dengan HIV negatif. Pemberian antibiotik pada pasien suspek TB paru sebagai alat bantu diagnosis TB paru tidak direkomendasikan lagi karena hal ini dapat menyebabkan keterlambatan diagnosis TB dengan konsekuensi keterlambatan pengobatan TB sehingga meningkatkan risiko kematian. Klasifikasi PCNE (Pharmaceutical Care Network Europe) dapat membantu tenaga kesehatan profesional untuk mendokumentasikan informasi-informasi mengenai DRPs (Drug Related Problem) yang terjadi dalam proses asuhan kefarmasian. Pada pasien Hematochezia dengan Anemia, TB Paru, dan SIDA perlu dilakukan kultur resistensi antibiotik untuk melihat antibiotik yang tepat untuk pengobatan pasien. Tahapan tatalaksana pemberian terapi hematochezia, TB terlebih dahulu kemudian dijeda dengan pemberian ARV juga dinilai sudah tepat.

---

therapy to recognize drug interactions early side effects can prevent unwanted drug reactions (ROTD) in patient treatment. Anemia can occur due to both acute and chronic bleeding resulting in a decrease in total red blood cells. Bleeding in the lower gastrointestinal tract with the release of fresh blood during bowel movements is called hematochezia. Extrapulmonary tuberculosis needs to be watched out for in people living with HIV/AIDS (PLWHA) because it occurs more frequently than TB with HIV negative. Giving antibiotics to patients with suspected pulmonary TB as a tool for diagnosing pulmonary TB is no longer recommended because this can cause a delay in the diagnosis of TB with consequent delays in TB treatment, thereby increasing the risk of death. The PCNE (Pharmaceutical Care Network Europe) classification can help health professionals to document information about DRPs (Drug Related Problems) that occur in the process of pharmaceutical care. In Hematochezia patients with Anemia, Pulmonary TB, and SIDA, it is necessary to carry out antibiotic resistance cultures to determine the appropriate antibiotic for treating the patient. The stages of management of giving hematochezia therapy, TB first and then stopping it with giving ARVs are also considered appropriate."

"Praktek Kerja Profesi Apoteker (PKPA) di rumah sakit bertujuan untuk memahami peran dan tanggung jawab Apoteker di rumah sakit, baik dalam hal pelayanan farmasi klinis maupun pengelolaan sediaan farmasi. Pemantauan terapi obat (PTO) adalah salah satu kegiatan farmasi klinik oleh Apoteker di rumah sakit untuk mengetahui keberhasilan ataupun kegagalan terapi obat. Berdasarkan hal tersebut, PTO dipilih sebagai tugas khusus PKPA di RSUP Fatmawati. Kegiatan ini dilakukan degan tujuan calon Apoteker dapat mengkaji pemilihan obat, dosis dan cara pemberian obat, respons terapi, reaksi obat yang tidak dikehendaki (ROTD), memantau efektivitas dan efek samping obat, dan memberikan rekomendasi penyelesaian masalah terkait obat atau DRP. Pemantauan obat dilakukan pada pasien dyspnea et causa suspek tumor paru dengan riwayat tuberkulosis di unit rawat inap gedung Teratai RSUP Fatmawati. PTO dilaksanakan dengan menganalisis DRP sesuai pedoman PCNE V9.0 dengan metode SOAP. Pada kasus ini, ditemukan beberapa DRP yang perlu dievaluasi kembali.

---

Pharmacist Professional Work Practice (PKPA) in hospitals aims to understand the roles and responsibilities of pharmacists in hospitals, both in terms of clinical pharmacy services and management of pharmaceutical preparations. Therapy drug monitoring (TDM) is one of the clinical pharmacy activities by pharmacists in hospitals to determine the success or failure of drug therapy. Based on this, TDM was chosen as a PKPA special assignment at Fatmawati Hospital. This activity is carried out with the aim that prospective pharmacists can review drug selection, dosage and method of drug administration, therapeutic response, unwanted drug reactions, monitor drug effectiveness and side effects, and provide recommendations for solving drug-related problems or DRP. Drug monitoring was carried out in patients with dyspnea et causa suspected lung tumors with a history of tuberculosis in the inpatient unit of the Teratai building at Fatmawati General Hospital. TDM is carried out by analyzing the DRP according to PCNE V9.0 guidelines using the SOAP method. In this case, several DRPs were found that needed to be re-evaluated."

"Perlekatan (adhesion) adalah suatu jaringan ikat fibrous seperti pita yang terbentuk antara jaringan dengan jaringan atau dengan organ yang secara normal tidak terbentuk.Perlekatan sering kali terbentuk sebagai akibat dari cedera sewaktu Tindakan operasi. Pengambilan data pasien dilakukan dengan metode pengambilan data secara prospektif, dengan kriteria pasien minimal 5 hari dirawat dan diberikan minimal 5 jenis obat. Pasien yang dilakukan Pemantaun Terapi Obat (PTO) sebanyak 3 pasien. Pencatatan penggunaan obat dilakukan setiap hari mengingat terkadang ada perubahan jenis obat yang diberikan dokter terkait kondisi klinis pasien. Pemantauan terapi obat pasien dilakukan pada bulan September 2020 dengan mengumpulkan data pasien. Data pasien yang dikumpulkan tersebut berupa data rekam medik dan pencatatan penggunaan obat (kardeks). Pemantauan terapi obat dilakukan pada pasien bernama Ny. LS di Ruang Kebidanan. Diagnosa masuk dari dokter yang menangani Ny. LS adalah POD V Post Laparoscopy HTSOB With Retrograde Adhesiolysis tetapi berdasarkan keterangan yang terdapat di rekam medik, pasien juga memiliki indiksi terinfeksi bakteri Mycobacterium tuberculosis, sehingga selama terapi pasien diberikan pengobatan tuberkulosis. Masalah interaksi obat terjadi pada pemakaian pyrazinamide dan rifampisin mememiliki tingkat interaksi obat mayor. pyrazinamide dan rifampisin secara bersamaan dapat menyebabkan cedera hati. Sedangkan omeprazole dan rifampisin memiliki tingkat interaksi moderate, dimana interaksi keduanya dapat menyebabkan penurunan konsentrasi plasma omeprazole. Pengobatan tanpa Indikasi terjadi pada pemberian KSR pada pasien karena hasil pemeriksaan laboratorium kadar kalium pasien normal serta pasien juga tidak sedang mengkonsumsi obat yang dapat menyebabkan hipokalemia.

---

Attachment (adhesion) is a connective tissue of fibrous like a ribbon formed between tissues with tissues or with organs that are not normally formed. Attachments are often formed as a result of injury during surgery. Patient data retrieval is done by prospective data retrieval method, with the criteria of patients at least 5 days treated and given at least 5 types of drugs. Patients conducted Drug Therapy Monitoring (PTO) as many as 3 patients. Recording of drug use is done every day considering that sometimes there is a change in the type of medicine given by the doctor related to the clinical condition of the patient. Monitoring of patient drug therapy was conducted in September 2020 by collecting patient data. The patient data collected in the form of medical record data and drug use record (kardeks). Monitoring of drug therapy was carried out on a patient named Mrs. LS in the Midwifery Room. The incoming diagnosis from the doctor who treated Mrs. LS was POD V Post Laparoscopy HTSOB With Retrograde Adhesiolysis but based on the information contained in the medical records, the patient also had an indication infected with the bacterium Mycobacterium tuberculosis, so that during therapy the patient was given tuberculosis treatment. Drug interaction problems occur in the use of pyrazinamide and rifampicin has a major level of drug interactions. pyrazinamide and rifampicin can simultaneously cause liver injury. While omeprazole and rifampicin have moderate levels of interaction, both interactions can lead to a decrease in plasma concentrations of omeprazole. Treatment without indication occurs in the administration of KSR in patients because the results of laboratory examination of potassium levels of normal patients and patients are also not taking drugs that can cause hypokalemia. "